BGC's Gillis: Apple's Dependence on China is Concerning (Audio)
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Colin Gillis, Director of Research and Senior Technology Analyst at BGC Financial, on Apple possibly having to halt iPhone sales in Beijing for patent infringement, and a look at Amazon's grocery business.See omnystudio.com/listener for privacy information.
17 Kesä 20168min
Bloomberg's Soshnick Previews NBA Championship Game 7 (Audio)
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox.\u0010\u0010GUEST:\u0010Scott Soshnick, Bloomberg Sports Reporter-at-large, previews Game 7 of the NBA championship between the Cleveland Cavaliers and the Golden State Warriors.See omnystudio.com/listener for privacy information.
17 Kesä 20165min
Bloomberg BNA's Gibson on Philadelphia Passing Soda Tax (Audio)
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox.\u0010\u0010GUEST:\u0010Annabelle Gibson, Managing Editor at Bloomberg BNA, on Philadelphia becoming the first US city to pass a soda tax.See omnystudio.com/listener for privacy information.
17 Kesä 20164min
Economist Buchholz on New Book: The Price of Prosperity (Audio)
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Economist Todd G. Buchholz, former White House Director of Economic Policy, on his new book: "THE PRICE OF PROSPERITY: Why Rich Nations Fail and How to Renew Them."See omnystudio.com/listener for privacy information.
17 Kesä 201611min
Axioma's Morokoff: Test Shows Brexit Could Trigger Crash(Audio)
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Bill Morokoff, Head of Research at Axioma, on their research report detailing the economic implications of a Brexit.See omnystudio.com/listener for privacy information.
17 Kesä 20168min
OPKO's Frost: BioReference Was a Tremendous Acquisition (Audio)
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Dr. Philip Frost, Chairman and CEO of OPKO Health, on the current landscape for the biotech industry, the company product pipeline, and drug pricing.See omnystudio.com/listener for privacy information.
16 Kesä 201611min
GW's Gover on Cannabis-Derived Drug for Rare Epilepsy (Audio)
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Justin Gover, CEO of GW Pharmaceuticals, on the drug pipeline for the UK- based company which has been developing drug treatments derived from cannabis for decades.See omnystudio.com/listener for privacy information.
16 Kesä 20168min
RBC's Golub on Investing in a Slow Growth Environment (Audio)
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. Guest: Jonathan Golub, Chief Equity Strategist for RBC Capital Markets, on the equity markets, the Fed, and investing in a slow growth environment.See omnystudio.com/listener for privacy information.
16 Kesä 201611min
